Karyopharm Therapeutics’s (KPTIQ) Moving Averages Convergence Divergence (MACD) indicator is -0.27, suggesting Karyopharm Therapeutics is a Sell.
Karyopharm Therapeutics’s (KPTIQ) 20-Day exponential moving average is 0.34, while Karyopharm Therapeutics’s (KPTIQ) share price is $0.02, making it a Sell.
Karyopharm Therapeutics’s (KPTIQ) 50-Day exponential moving average is 1.15, while Karyopharm Therapeutics’s (KPTIQ) share price is $0.02, making it a Sell.
Karyopharm Therapeutics’s (KPTIQ) 10-Day exponential moving average is 0.16, while Karyopharm Therapeutics’s (KPTIQ) share price is $0.02, making it a Sell.
Karyopharm Therapeutics’s (KPTIQ) 100-Day exponential moving average is 2.70, while Karyopharm Therapeutics’s (KPTIQ) share price is $0.02, making it a Sell.
Karyopharm Therapeutics’s (KPTIQ) stock price is $0.02 and Karyopharm Therapeutics’s (KPTIQ) 50-day simple moving average is 0.92, creating a Sell signal.
Karyopharm Therapeutics’s (KPTIQ) stock price is $0.02 and Karyopharm Therapeutics’s (KPTIQ) 100-day simple moving average is 3.33, creating a Sell signal.
Karyopharm Therapeutics’s (KPTIQ) stock price is $0.02 and Karyopharm Therapeutics’s (KPTIQ) 200-day simple moving average is 5.78, creating a Sell signal.